Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeen Liu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|January 8, 2019
Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controlsJiacheng Yuan, Jeen Liu, Ray Zhu, et al.
Journal of Biopharmaceutical Statistics|December 5, 2022
Causal inference for longitudinal data based on historical controlsJeen Liu, Jane Zhang, Alan Mitchell, et al.
Pharmaceutical Statistics|August 22, 2020
Evaluation of alternative confidence intervals to address non-inferiority through the stratified difference between proportionsJiatong Sui, Jenny Jiao, Yijun Sun, et al.
Contemporary Clinical Trials Communications|July 14, 2018
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose findingJiacheng Yuan, Daniel Radecki, Denise Bugarin, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on SafetyJiacheng Yuan, Peter Mesenbrink, Jihao Zhou, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2003
Omalizumab is effective in the long-term control of severe allergic asthmaBobby Quentin Lanier, Jonathan Corren, William Lumry, et al.
International Clinical Psychopharmacology|October 15, 2019
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult femalesMitchell F Brin, Suresh Durgam, Arlene Lum, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
Omalizumab improves asthma-related quality of life in patients with severe allergic asthmaAlbert Finn, Gary Gross, Julius van Bavel, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2020
Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of BiasJessica Lim, Li Wang, Nicky Best, et al.
Therapeutic Innovation & Regulatory Science|June 19, 2018
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and OpportunitiesJessica Lim, Rosalind Walley, Jiacheng Yuan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|January 8, 2019
Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controlsJiacheng Yuan, Jeen Liu, Ray Zhu, et al.
Journal of Biopharmaceutical Statistics|December 5, 2022
Causal inference for longitudinal data based on historical controlsJeen Liu, Jane Zhang, Alan Mitchell, et al.
Pharmaceutical Statistics|August 22, 2020
Evaluation of alternative confidence intervals to address non-inferiority through the stratified difference between proportionsJiatong Sui, Jenny Jiao, Yijun Sun, et al.
Contemporary Clinical Trials Communications|July 14, 2018
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose findingJiacheng Yuan, Daniel Radecki, Denise Bugarin, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on SafetyJiacheng Yuan, Peter Mesenbrink, Jihao Zhou, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2003
Omalizumab is effective in the long-term control of severe allergic asthmaBobby Quentin Lanier, Jonathan Corren, William Lumry, et al.
International Clinical Psychopharmacology|October 15, 2019
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult femalesMitchell F Brin, Suresh Durgam, Arlene Lum, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
Omalizumab improves asthma-related quality of life in patients with severe allergic asthmaAlbert Finn, Gary Gross, Julius van Bavel, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2020
Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of BiasJessica Lim, Li Wang, Nicky Best, et al.
Therapeutic Innovation & Regulatory Science|June 19, 2018
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and OpportunitiesJessica Lim, Rosalind Walley, Jiacheng Yuan, et al.
Pageof 2